Fundz

CollimateHealth has raised €6 million in seed funding from HTGF and VP Venture Partners to develop innovative microbeam radiation therapy.

PRIVATEJun 15, 2026

Amount Raised

€6 Million

Round Type

Seed

MunichBiotechnologyHealth Care

Investors

CaesarHigh Tech GründerfondsXista Science VenturesPositronVP Venture PartnersHtgf

Description

CollimateHealth has raised €6 million in seed funding to advance microbeam radiation therapy, targeting tumors while boosting the immune system. Backed by HTGF and VP Venture Partners, the startup is leveraging nearly a decade of research. The funding will support efforts to treat its first patients by the end of 2028. With a market poised for growth, this innovative approach aims to improve cancer treatment outcomes.

Quick answer

CollimateHealth raised €6 Million in a Seed round, dated June 15, 2026. Investors: Caesar, High Tech Gründerfonds, Xista Science Ventures, Positron, VP Venture Partners and Htgf. CollimateHealth is based in Munich, Bavaria, Germany.

How much did CollimateHealth raise?
CollimateHealth raised €6 Million in a Seed round on June 15, 2026.
Who invested in CollimateHealth?
Caesar, High Tech Gründerfonds, Xista Science Ventures, Positron, VP Venture Partners and Htgf are named as investors in this round.
What does CollimateHealth do?
CollimateHealth is a startup focused on developing microbeam radiation therapy, an innovative cancer treatment method that utilizes very thin radiation beams to specifically target tumors while enhancing the immune..
Where is CollimateHealth based and how big is it?
CollimateHealth is based in Munich, Bavaria, Germany.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as CollimateHealth that raised within 45 days of this round, from Fundz verified event records.

  • Hyku Biosciences raised $8.6M on July 30, 2026.
  • Function raised $450M on July 30, 2026.
  • Beyond Air raised $30M (Post-IPO Equity) on July 30, 2026.
  • Sail Biomedicines raised $465M on July 30, 2026.
  • SoundHealth raised $12M (Series A) on July 30, 2026.
  • Adjuvia Therapeutics raised $8M (Seed) on July 29, 2026.

Who to call at CollimateHealth, and when

A new round usually means CollimateHealth is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CollimateHealth raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CollimateHealth, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CollimateHealth. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CollimateHealth

Location

Munich, Bavaria, Germany

About

CollimateHealth is a startup focused on developing microbeam radiation therapy, an innovative cancer treatment method that utilizes very thin radiation beams to specifically target tumors while enhancing the immune system. The company originated from nearly a decade of research at the Technical University of Munich, aiming to create a more effective radiation therapy with reduced harm to healthy tissue. Backed by several European life sciences investors, CollimateHealth is positioned to advance its solution in the rapidly evolving field of oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CollimateHealth raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for CollimateHealth's next move

See what Strategic adds

CollimateHealth raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.